Claire Mazumdar Bicara Therapeutics Inc. (BCAX) insider trading activity

Shares Held (Direct Ownership) 310K

n/a 3M change

n/a 12M change

Total Value Held N/A

Claire Mazumdar Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 16 2025	SELL Open market or private sale	$453,859 $18.83 p/Share	24,103 Reduced 7.22%	309,892 Common Stock
Oct 16 2025	BUY Exercise of conversion of derivative security	$91,350 $3.79 p/Share	24,103 Added 6.73%	333,995 Common Stock
Oct 15 2025	SELL Open market or private sale	$250,364 $18.84 p/Share	13,289 Reduced 4.11%	309,892 Common Stock
Oct 15 2025	BUY Exercise of conversion of derivative security	$50,365 $3.79 p/Share	13,289 Added 3.95%	323,181 Common Stock
Oct 13 2025	SELL Open market or private sale	$216,539 $18.92 p/Share	11,445 Reduced 3.56%	309,892 Common Stock
Oct 13 2025	BUY Exercise of conversion of derivative security	$43,376 $3.79 p/Share	11,445 Added 3.44%	321,337 Common Stock

RLAY

Relay Therapeutics, Inc. Healthcare

Chief Executive Officer

Cambridge, MA

Receive a notification when an Institution or Guru buys or sells BCAX shares.

Notify only if

Value

Get notified when an Bicara Therapeutics Inc. insider buys or sells BCAX shares.

Notify only if

Operation

Value

Type

Receive news related to Bicara Therapeutics Inc.